2/17
Positive
Late treatment study
Yanrong, deputy head of the China National Center for Biotechnology Development (News) (not included in the study count)
Antimalarial drug confirmed effective on COVID-19
HC Q under clinical trials in >10 hospitals in China and has shown fairly good efficacy.
Currently no formal study is available so this is not included in the study count.